Antonio Llombart Cussac | Hospital Quirónsalud Valenciawww.quironsalud.es › valencia › medical-team › antonio-llombart-cussac
www.quironsalud.es
Born in Valencia (1964) he is currently Head of the Medical Oncology Service at the Arnau de Vilanova Hospital in Valencia, coordinator of the Breast Cancer ...
LinkedIn: Antonio Llombart Cussac | LinkedIn
Ver el perfil profesional de Antonio Llombart Cussac en LinkedIn. LinkedIn es la red de negocios más grande del mundo que ayuda a profesionales como ...
WikiGenes - Antonio Llombart-Cussac
www.wikigenes.org
Antonio Llombart-Cussac. Medical Oncology Service. Biomedical Research Institute. Arnau de Vilanova University Hospital. Lleida. Spain. [.es.
ANTONIO LLOMBART-CUSSAC - Loop Frontiersloop.frontiersin.org › people › overview
loop.frontiersin.org
ANTONIO LLOMBART-CUSSAC. Assistant Professor. Department of Medical Oncology, University Hospital Arnau of Vilanova. Lleida, Spain. View All.
Six Months of Trastuzumab Effective in HER2+ Breast Cancerwww.medscape.com › viewarticle
www.medscape.com
Sep 20, · Dr Antonio Llombart-Cussac, Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain, who was not involved in the study, ...
Researchgate: Antonio Llombart-Cussac
Valencia, Spain
Antonio Llombart-Cussac, MD, PhD
www.onclive.com
Oct 7, · Antonio Llombart-Cussac, MD, PhD. home · authors; antonio-llombart-cussac-md-phd. Articles. Dr. Llombart-Cussac on Eribulin in HER2-Negative ...
Antonio Llombart-Cussac, MD, PhD | Authors - Targeted Oncologywww.targetedonc.com › authors › antonio-llombart-cussac-md-phd
www.targetedonc.com
One Expert's Vision for Breast Cancer Treatment in the Next 5 to 10 Years ... Antonio Llombart-Cussac, MD, PhD, medical oncologist, chairman, Medical Oncology ...
Lymphopenia in hospitalized patients and its relationship PLOSjournals.plos.org › plosone › article › authors › journal.pone
journals.plos.org
Aug 13, · Affiliation Clinical Documentation Department, Arnau de Vilanova-Lliria University Hospital. Valencia, Spain. Antonio Llombart-Cussac.
A prognostic factor index for overall survival in patients receiving...
www.sciencedirect.com
Antonio Llombart-Cussac a, b, *. , Xavier Pivot c, Laura Biganzoli d, Hernan Cortes-Funes e,. Kathleen I. Pritchard f, Jean-Yves Pierga g, Ian Smith h, Christoph ...
A prognostic factor index for overall survival in patients receiving first ...pubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Antonio Llombart-Cussac , Xavier Pivot , Laura Biganzoli , Hernan Cortes-Funes , Kathleen I Pritchard , Jean-Yves Pierga , Ian Smith , Christoph Thomssen ...
A polymorphism at the 3'-UTR region of the aromatase gene defines a...
bmccancer.biomedcentral.com
Zaida Garcia-Casado†,; Angel Guerrero-Zotano†,; Antonio Llombart-Cussac,; Ana Calatrava,; Antonio Fernandez-Serra,; Amparo Ruiz-Simon,; Joaquin Gavila, ...
Publications Authored by Antonio Llombart-Cussac | PubFacts
www.pubfacts.com
Publications Authored by Antonio Llombart-Cussac
Create a SciFeed alert for new publications - MDPIwww.mdpi.com › scifeed_display
www.mdpi.com
Beatriz Honrubia-Peris. Javier Garde-Noguera. Jose García-Sánchez. Nuria Piera-Molons. Antonio Llombart-Cussac. María Leonor Fernández-Murga ...
Antonio Llombart-Cussac | PubFactswww.pubfacts.com › author › Antonio+Llombart-Cussac
www.pubfacts.com
Importance: The cyclin-dependent kinase 4 and 6 inhibitor palbociclib in combination with letrozole has become a standard first-line treatment for patients ...
Antonio Llombart, MD @harnaulleida @wearemedsir - Oncology Tubewww.oncologytube.com › video › antonio-llombart-md-harnaulleida-wear...
oncologytube.com
Jan 11, · Antonio Llombart-Cussac, MD, Ph.D. founding partner of Medica Scientia Innovation Research (MedSIR) and the Hospital Arnau de Vilanova ...
Nobody dares stopping clinical research, not even COVID Naturewww.nature.com › npj breast cancer › comment
www.nature.com
Apr 8, · Antonio Llombart-Cussac. Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain. Antonio Llombart-Cussac.
All web results to the name "Antonio Llombart"
June 25, EPOV Antonio Llombart-Cussac - The ASCO Postascopost.com › issues › june › epov-antonio-llombart-cussac
ascopost.com
Jun 25, · Discussant of the abstracts, Antonio Llombart-Cussac, MD, PhD, of Hospital Arnau de Vilanova, Universidad Catolica Valencia, Spain, ...
Just a moment...
clincancerres.aacrjournals.org
A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer. Antonio Llombart-Cussac 1,
Critically short telomeres and toxicity of chemotherapy in early ...www.oncotarget.com › article
www.oncotarget.com
Mar 28, · ... Noelia Martinez-Jánez7, Antonio Gonzalez-Martin10, Encarna Adrover11, Raquel de Andres12, Gemma Viñas13, Antonio Llombart-Cussac14, ...
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically ...www.scholars.northwestern.edu › publications › overall-survival-of-cdk
www.scholars.northwestern.edu
Nov 1, · ... Pierfranco Conte, Dejan Juric, Antonio Llombart-Cussac, Lajos Pusztai, Aleix Prat, Guy Jerusalem, Angelo Di Leo, Daniele Generali.
Phase II trial with letrozole to maximum response as primary ...www.infona.pl › resource
www.infona.pl
Antonio Llombart-Cussac, Ángel Guerrero, Antonio Galán, Vicente Carañana, Elvira Buch, Álvaro Rodríguez-Lescure, Amparo Ruiz, … [ more ].
Related search requests for Antonio Llombart
| Instituto Valenciano Elena Aguirre Vicente Felipo |
People Forename "Antonio" (55130) Name "Llombart" (66) |
sorted by relevance / date